Skip to main content

rimepagent (Vydura®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal TA906: Rimegepant for preventing episodic migraine

Medicine details

Medicine name rimepagent (Vydura®)
Formulation oral
Reference number 5281
Indication

For preventing episodic migraine

Company Pfizer Ltd
BNF chapter Central nervous system
Submission type N/A
Status Excluded due to NICE appraisal
Date of issue 31/05/2023
NICE guidance

TA906: Rimegepant for preventing episodic migraine

Follow AWTTC: